ALOX5AP, arachidonate 5-lipoxygenase activating protein, 241
N. diseases: 76; N. variants: 20
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
13 | 30739088 | intron variant | C/A;G | snv | 1.3E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
13 | 30739088 | intron variant | C/A;G | snv | 1.3E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
13 | 30740318 | intron variant | C/A | snv | 0.58 |
|
0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||||
|
0.776 | 0.320 | 13 | 30737959 | intron variant | A/T | snv | 0.52 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.776 | 0.320 | 13 | 30737959 | intron variant | A/T | snv | 0.52 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.776 | 0.320 | 13 | 30737959 | intron variant | A/T | snv | 0.52 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Cardiovascular Diseases | 0.010 | < 0.001 | 1 | 2015 | 2015 | |||||||
|
0.776 | 0.320 | 13 | 30737959 | intron variant | A/T | snv | 0.52 |
|
Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.776 | 0.320 | 13 | 30737959 | intron variant | A/T | snv | 0.52 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.776 | 0.320 | 13 | 30737959 | intron variant | A/T | snv | 0.52 |
|
Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.776 | 0.320 | 13 | 30737959 | intron variant | A/T | snv | 0.52 |
|
Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.776 | 0.320 | 13 | 30737959 | intron variant | A/T | snv | 0.52 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Respiratory Tract Diseases; Hemic and Lymphatic Diseases | 0.010 | < 0.001 | 1 | 2014 | 2014 | |||||||
|
1.000 | 0.080 | 13 | 30738041 | intron variant | A/T | snv | 0.24 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.080 | 13 | 30738041 | intron variant | A/T | snv | 0.24 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.925 | 0.160 | 13 | 30756000 | missense variant | G/A;C | snv | 8.0E-06; 4.0E-06 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.160 | 13 | 30756000 | missense variant | G/A;C | snv | 8.0E-06; 4.0E-06 |
|
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.120 | 13 | 30737959 | intron variant | A/T | snv |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.925 | 0.120 | 13 | 30737959 | intron variant | A/T | snv |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.925 | 0.120 | 13 | 30737959 | intron variant | A/T | snv |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.080 | 13 | 30734192 | intron variant | T/A;G | snv |
|
Nervous System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
13 | 30744171 | non coding transcript exon variant | C/A | snv | 0.49 | 0.45 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
13 | 30744264 | non coding transcript exon variant | T/C | snv | 0.20 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||||
|
0.882 | 0.160 | 13 | 30732134 | intron variant | G/A | snv | 0.49 |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.882 | 0.160 | 13 | 30732134 | intron variant | G/A | snv | 0.49 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.882 | 0.160 | 13 | 30732134 | intron variant | G/A | snv | 0.49 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.120 | 13 | 30745981 | intron variant | T/C | snv | 0.50 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 |